
Sign up to save your podcasts
Or
For the first episode of the new video podcast, Matt turns the tables on Brad Loncar and interviews him about his experiences and knowledge of investing in China biotech over the years. They discuss the rise of China biotech and how it might or might not be impacting M&A in the sector.
5
44 ratings
For the first episode of the new video podcast, Matt turns the tables on Brad Loncar and interviews him about his experiences and knowledge of investing in China biotech over the years. They discuss the rise of China biotech and how it might or might not be impacting M&A in the sector.
110,845 Listeners
316 Listeners
30 Listeners
11 Listeners
4 Listeners
0 Listeners
2 Listeners
4 Listeners